Thrombin Receptor Activating Peptide (TRAP) Stimulates Mitogenesis, c-fos and PDGF-A Gene Expression in Human Vascular Smooth Muscle Cells

Summary

The synthetic peptide SFLLRNPNDKYEPF, identical in sequence to the new amino-terminus of the thrombin receptor generated following cleavage by thrombin, acts as a thrombin receptor agonist/ activating peptide (TRAP). In this study, Northern blot analysis showed that cultured human vascular smooth muscle cells (HVSMC) express a thrombin receptor transcript. TRAP, in contrast to thrombin was shown to be a weak mitogen for HVSMC. A combination of TRAP and enzymatically-inactivated thrombin (PPACK-thrombin) which provides receptor occupancy, did not potentiate TRAP-induced mitogenesis, indicating that TRAP and PPACK-thrombin do not reproduce the mitogenic effect of enzymatically-active thrombin. Both thrombin and TRAP, induced the expression of c-fos and the PDGF-A gene in a pertussis toxin (PTX)-insensitive manner. Examination of thrombin and TRAP-treated cells by immunofluorescence staining followed by computer assisted image analysis revealed that thrombin and to a lesser extent TRAP induced PDGF-AA protein expression. Antibodies to PDGF-AA partially inhibited thrombin but not TRAP-induced mitogenesis in HVSMC. This study indicates that in addition to the common signalling pathways utilised by thrombin and TRAP, enzymatically-active thrombin activates other signalling pathways and hence TRAP does not mimic fully the biological effect of thrombin on HVSMC.

• References

• 1 Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-809
• 2 Wissler RW. Update on the Pathogenesis of Atherosclerosis. Am J Med 1991; 91 1B 3S-9S
• 3 Huang CL, Cogan MG, Cragoe EJ, Ives HE. Thrombin activation of the Na+/H+ exchanger in vascular smooth muscle cells. Evidence for a kinase C-independent pathway which is Ca²⁺-dependent and pertussis toxin sensitive J Biol Chem 1987; 262: 14134-14140
• 4 Kanthou C, Parry G, Wijelath E, Kakkar VV, Demoliou-Mason C. Thrombin-induced proliferation and expression of platelet-derived growth factor-A chain gene in human vascular smooth muscle cells. FEBS Lett 1992; 314: 143-148
• 5 McNamara CA, Sarembock IJ, Gimple LW, Fenton II JW, Coughlin SR, Owens GK. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor. J Clin Invest 1993; 91: 94-98
• 6 Bar-Shavit R, Benezra M, Eldor A, Hy-Am E, Fenton II JW, Vlodavsky I. Thrombin immobilized to extracellular matrix is a potent mitogen for vascular smooth muscle cells: Nonenzymatic mode of action. Cell Regul 1990; 1: 453-463
• 7 Harmon JT, Jamieson GA. The glycoprotein portion of platelet glycoprotein b expressed both high and moderate affinity receptor sites for thrombin. A soluble radioreceptor assay for the interaction of thrombin with platelets J Biol Chem 1986; 261: 13224-13229
• 8 Garcia JG N, Aschner JL, Malik AB. Regulation of thrombin-induced endothelial barrier dysfunction and prostaglandin synthesis. In: Thrombin, Structure and Function. Berliner LJ. ed. Plenum Press; New York and London: 1992. pp 397-430
• 9 Bar-Shavit R, Kahn A, Fenton II JW, Wilner GD. Chemotactic response of monocytes to thrombin. J Cell Biol 1983; 96: 282-285
• 10 Vu T-KH, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991; 64: 1057-1068
• 11 Rasmussen UB, Vouret-Craviari V, Jallat S, Schlesinger Y, Pages G, Pavirani A, Lecocq J-P, Pouyssegur J, Van Obberghen-Schilling E. cDNA cloning and expression of a hamster a-thrombin receptor coupled to Ca²⁺mobilization. FEBS Lett 1991; 288: 123-128
• 12 Herbert JM, Lamarche I, Dol F. Induction of vascular smooth muscle cell growth by selective activation of the thrombin receptor. FEBS Lett 1992; 301: 155-158
• 13 Dohlman HG, Thorner J, Caron GM, Lefkowitz RJ. Model systems for the study of seven-transmembrane segment receptors. Annu Rev Biochem 1991; 60: 653-688
• 14 Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. (First of Two Parts) New Eng J Med 1992; 326: 242-250
• 15 Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. (Second of Two Parts) New Eng J Med 1992; 326: 310-318
• 16 Wilcox JN, Rodriguez J, Subramanian R, Ollerenshaw J, Zhong C, Hayzer DJ, Horaist C, Hanson SR, Lumsden A, Salam TA, Kelly AB, Harker LA, Runge M. Characterisation of thrombin receptor expression during vascular lesion formation. Cir Res 1994; 75: 1029-1038
• 17 Nelken NA, Soifer SJ, O’Keefe J, Vu TK, Cham IK, Coughlin SR. Thrombin receptor expression in normal and atherosclerotic human arteries. J Clin Invest 1992; 90: 1614-1621
• 18 Sarembock IJ, Ciertz SD, Gimple LW, Owen RM, Powers HR, Roberts WC. Effectiveness of recombinant desulphatohirudin in reducing restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits. Circ Res 1991; 84: 232-243
• 19 Walters TK, Gorog DA, Wood RF M. Thrombin generation following arterial injury is a critical initiating event in the pathogenesis of the proliferative stages of the atherosclerotic process. J Vase Res 1994; 31: 173-177
• 20 Vassallo RR, Kieber-Emmons T, Gichowski K, Brass LF. Structure-function relationships in the activation of platelet thrombin receptors by receptor-derived peptides. J Biol Cheni 1992; 267: 6081-6085
• 21 Ngaiza JR, Jaffe EA. A 14 amino-acid peptide derived from the amino terminus of the cleaved thrombin receptor elevates intracellular calcium and stimulates prostacycline production by human endothelial cells. Biochem Biophys Res Commun 1991; 179: 1656-1661
• 22 Vouret-Craviari V, Van Obberghen-Sehilling E, Rasmussen UB, Paviran A, Lecocq J-P, Pouyssegur J. Synthetic α-thrombin receptor peptides activate G-protein coupled signalling pathways but are unable to induce niitogenesis. Mol Biol Cell 1992; 3: 95-102
• 23 Sambrook J, Maniatis T, Fritsch EE. Molecular Cloning: A laboratory manual. Cold Spring Harbor Laboratory Press; 1989. pp 7.1-7.87
• 24 Pringle N, Collarini EJ, Moslev MJ, Heldin CH, Westermark B, Richardson WD. PDGF-A chain homodimers drive proliferation of bipotential (0-2A) glial progenitor cells in the developing rat optic nerve. EMBOJ 1989; 8: 1049-1056
• 25 Persico MG, Viglietto G, Martini G, Toniolo D, Paonessa G, Moscatelli C, Dono R, Vulliamy T, Luzzatto L, D’Urso M. Isolation of human glucose-6-phosphate dehydrogenase (G6PD) cDNA clones: primary structure of the protein and unusual 5’ non-coding region. Nucleic Acids Res 1986; 14: 2511-2522
• 26 Treisman R. Transient accumulation of c-fos RNA following serum stimulation requires a conserved 5 element and c-fos 3 sequences. J Cell 1985; 42: 889-902
• 27 Coller BS, Ward P, Ceruso M, Scudder LE, Springer K, Kutok J, Prestwich GD. Thrombin receptor activating peptides: importance of the N-terminal serine and its ionization state as judged by pH dependence, nuclear magnetic resonance spectroscopy, and cleavage by aminopeptidase M. Biochemistry 1992; 31: 11713-11720
• 28 Carney DH, Herbosa GJ, Stiernberg J, Bergmann JS, Gordon EA, Scott D, Fenton II JW. Double-signal hypothesis for thrombin initiation of cell proliferation. Semin Thromb Hemostas 1986; 12: 231-240
• 29 Obberghen-Schilling EV, Pouyssegur J. α-Thrombin receptors and growth signalling. Semin Thromb Haem 1993; 19: 378-385
• 30 Okazaki H, Majesky MW, Harker LA, Schwartz SM. Regulation of platelet-derived growth factor ligand and receptor gene expression by a thrombin in vascular smooth muscle cells. Circ Res 1992; 71: 1285-1293
• 31 Weiss RH, Ives HE. Dissociation between activation of growth-related genes and mitogenic responses of neonatal vascular smooth muscle cells. Biochem Biophys Res Comm 1991; 181: 617-622
• 32 Battegay EJ, Raines EW, Seifert RA, Bowen-Pope DF, Ross R. TGF-beta induces bimodel proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell 1990; 63: 515-524
• 33 Raines EW, Dower SK, Ross R. Interleukin I mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. Science 1989; 243: 393-396
• 34 Bonthron DT, Morton CC, Orkin SH, Collins T. Platelet-derived growth factor A chain: Gene structure, chromosomal location and basis for alternative mRNA splicing. Proc Nat Acad Sei USA 1988; 85: 1492-1496
• 35 Anderson M, Ostman A, Westermark B, Heldin C-H. Characterisation of the retention motif in the C-terminal part of the long splice form of platelet-derived growth factor A-chain. J Biol Chem 1994; 269: 926-930
• 36 Raines EW, Ross R. Compartmentalisation of PDGF on extracellular binding sites dependent on exon-6-encoded sequences. J Cell Biol 1992; 116: 533-543
• 37 Hatton MW, Moar SL, Richardson M. Deendothelialization in vivo initiates a thrombogenic reaction at the rabbit aorta surface. Correlation of uptake of fibrinogen and antithrombin III with thrombin generation by the exposed subendothelium Am J Pathol 1989; 135: 499-508
• 38 Hedin U, Frebelius S, Sanchez J, Dryjski M, Swedenborg J. Antithrombin III inhibits thrombin-induced proliferation in human arterial smooth muscle cells. Arterioscler Thromb 1994; 14: 254-260
• 39 Cockroft S, Thomas GM H. Inositol-lipid-specific phospholipase C isoenzymes and their differential regulation by receptors. Biochem J 1992; 288: 1-14
• 40 Chambard JC, Paris S, L’Allemain G, Pouyssegur J. Two growth factor signalling pathways in fibroblasts distinguished by pertussis toxin. Nature 1987; 326: 800-803
• 41 Benezra M, Vlodavsky I, Ishai-Michaeli R, Neufeld G, Bar-Shavit R. Thrombin-induced release of active basic fibroblast growth factor-heparan sulfate complexes from subendothelial extracellular matrix. Blood 1993; 81: 3324-3331
• 42 Soyombo AA, DiCorleto PE. Stable expression of human platelet-derived growth factor B-chain by bovine aoritc endothelial cells. Matrix association and selective proteolytic cleavage by thrombin J Biol Chem 1994; 269: 17734-17740
• 43 De Marco L, Mazzucato M, Masotti A, Ruggeri ZM. Localisation and characterisation of an α-thrombin-binding site on platelet glycoprotein Ibα. J Biol Chem 1994; 269: 6478-6484
• 44 Shankar R, Dela Motte CA, Poptic EJ, DiCorletto PE. Thrombin receptor activating peptides differentially stimulated platelet-derived growth factor production, monocytic cell adhesion and E-selectin expression in human umbilical endothelial cells. J Biol Chem 1994; 269: 13936-13941
• 45 Lau L-F, Pumiglia K, Cote YP, Feinstein MB. Thrombin receptor agonist peptides, in contrast to thrombin itself are not full agonists for activation and signal transduction in human platelets in the absence of platelet-derived secondary mediators. Biochem J 1994; 303: 391-400
• 46 Vouret-Craviari V, Van Obberghen-Sehilling E, Scimeca J-C, Van Obberghen E, Pouyssegur J. Differential activation of p44mapk (ERK1) by α-thrombin and synthetic receptor peptide agonists. Biochem J 1993; 289: 209-214